By Devin Partida, Editor-in-Chief, ReHack.com
LinkedIn: Devin Partida
LinkedIn: ReHack Magazine
The digitalization of health care attracts strong capital interest. Current systems need greater efficiency. Emerging technologies promise meaningful clinical and administrative gains. Despite this, many promising innovations still struggle to secure digital health startup funding, even if they work. The gap often lies in a misalignment between vision and operational realities. This is where many founders lose investor confidence.
Lack of a Clear Clinical Value Proposition
Industry research shows that 98% of health startups fail within five years, often because they present their technology without clearly identifying the specific problem they’re trying to solve. Founders often miss the mark by vaguely framing products as “faster” or “more efficient” than existing tools. Broad descriptions rarely persuade financial stakeholders.
Failure to Address Regulatory Hurdles
Many health tech developers underestimate the strict demands of HIPAA. Instead of treating compliance as a core design principle, teams address regulations late in development. This exposes users to risk without the team realizing it and increases the likelihood of data breaches. Health care already records the highest breach costs across industries, with an average of $10.92 million per incident. Events like these quickly erode both investor and patient trust.
Regulatory confusion also appears in product approval pathways. Some teams misinterpret the FDA’s risk-based framework. Their solutions then fall into regulated medical device categories, leading to delays as companies pursue the appropriate clearances. As artificial intelligence (AI) and complex international rules like the EU’s EHDS become more prevalent, developers unprepared for these niche yet growing hurdles will find themselves unable to compete.
Misalignment With Real Needs
Among the most common reasons innovations fail is the weak connection to real clinical problems. Digital health founders who enter the sector with strong engineering backgrounds see opportunities in AI, wearable data or remote monitoring platforms. In reality, funders look beyond technical performance. A product may work well in a pilot or lab setting. However, investors still need clear evidence that it supports actual care delivery, integrates with their existing systems and improves measurable outcomes.
Strategies That Attract Digital Health Investment
Despite the odds these barriers present, a handful of companies still successfully secure funding for their digital health startup. Their approaches share several common patterns.
1. Demonstrate Measurable Clinical Impact
It may feel easier to write broad problem statements. Many competitors take the same approach. Yet claims about improving a workflow sound hollow without showing exactly how the product does it. Industry leaders expect direct answers to three questions:
- Which patient outcomes does it improve?
- How do clinical staff benefit during care delivery?
- What cost savings or revenue improvements appear?
Precise language does not require heavy jargon. It means being specific enough that readers understand the idea without getting lost in complex industry terminology. Clinical trials and pilot studies help strengthen that clarity. They add credibility to the claims being made. Investors respond well to evidence supported by real-world results.
2. Engage Clinicians During Product Design
No one understands the actual use case better than the professionals expected to use the product. Early collaboration with physicians and nurses helps surface operational challenges that might otherwise be overlooked. Their real-world experience can uncover invaluable insights that shape the development and support its long-term success.
3. Build Partnerships Across the Health Care Ecosystem
The broader health care ecosystem includes hospitals, insurers and technology partners who may benefit. Evaluating their needs helps determine whether the innovation addresses shared challenges or introduces new friction. This wider perspective strengthens credibility and provides access to more reliable data, showing that the product is not a siloed solution.
That alignment also supports interoperability, which remains a policy priority under the Health Information Technology for Economic and Clinical Health Act. Solutions that exchange information across departments and vendors make adoption practical.
4. Develop a Business Plan That Resonates
A strong business plan explains how the product drives revenue and how the company grows in health care markets as more clinics adopt it. Understanding how hospitals actually pay for services is key to this plan.
In the United States, payment often depends on insurance billing rules and many medical services are reimbursed through Current Procedural Terminology (CPT) codes. If a digital health solution fits into an existing billing code, hospitals already know how they will get paid for using it, which makes adoption easier. Venture partners favor clear pricing and reimbursement alignment because CPT-approved products are perceived as lower risk, providing visibility into the expected revenue path.
Turn Innovation Into Fundable Solutions
Even the most promising innovations need more than technical brilliance. Founders must align products with real clinical needs, workflow realities and reimbursement pathways. By validating solutions with health care stakeholders and demonstrating measurable value, companies can make a compelling case for digital health startup funding.